EarningsQ2 2026 Earnings Report
DE:3KF0 Q2 2026 EPS Results
Actual EPS€0.04
Consensus EPS€0.04
Beat/MissMet expectations
One Year Ago EPS€0.06
DE:3KF0 Q2 2026 Revenue Results
Actual Revenue€29.25M
Expected Revenue€26.24M
Beat/MissBeat by +€3.00M
YoY Revenue Growth+18.05%
Earnings Announcement Details
QuarterQ2 2026
Date08/13/2026
TimeBefore Open
Conference CallThursday, August 13, 2026
DE:3KF0 Upcoming Earnings
Auxly Cannabis Group's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:3KF0 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call presents multiple strong operational and financial positives: double-digit revenue growth (+18% YoY), improving gross margins (55%, +3pp), record adjusted EBITDA (+24% YoY) and very strong cash conversion (94%). Product innovation and distribution momentum (Liquid Imagination, Back Forty, Galactic Jack) and an articulated $30M 3-year capital plan to raise yields are constructive. Offsetting items are accounting-driven net income volatility from noncash fair-value adjustments, higher SG&A to support growth, modest net debt (~$6M), and execution/funding risk related to the multi-year capacity expansion and cautious stance on international expansion. Overall, the highlights materially outweigh the lowlights.Company Guidance
Record Quarterly Financial Performance
Net revenue of $45.8M, up 18% year-over-year; adjusted EBITDA of $14.3M, up 24% year-over-year, representing an EBITDA margin of 31% (sustained for five consecutive quarters).
Strong Cash Generation and Conversion
Cash flow from operations before working capital changes of $13.4M, up 31% year-over-year, with a 94% conversion rate from adjusted EBITDA to cash flow.
Improving Gross Margin
Gross margin on finished cannabis inventory sold improved to 55% from 52% (a 3 percentage-point increase), reflecting higher cultivation yields, manufacturing improvements, strategic procurement and a favorable product mix.
Healthy Balance Sheet and Shareholder Returns
Cash balance of $38M with $44M of long-term debt (net debt approx. $6M). Deployed $5.7M in the quarter to repurchase 2.6M post-consolidation shares under the NCIB; completed a 14-for-1 share consolidation and reported positive share-price response.
Product Innovation & Distribution Wins
New product successes: Liquid Imagination remains the top-selling strain in Canada for over 2 years; Back Forty pre-rolls have become a leading pre-roll brand; Galactic Jack (new sativa cultivar) achieved ~1,400 points of distribution early and has received strong consumer feedback; South Point is a top-40 flower brand nationally with plans to expand SKUs.
Capital Investment Plan to Drive Capacity
Outlined a longer-term capital program of ~ $30M over the next 3 years (including $10–$12M guided for 2026) to increase yield at Auxly Leamington by ~30% over 2025 levels, with the company expecting to fund investments from cash from operations.
Operational Discipline and Structural Margin Improvement
Management attributed margin gains to structural improvements (higher yields, manufacturing efficiencies, procurement savings such as reduced vape API cost) and disciplined SG&A management targeting growth rates aligned with revenue.
DE:3KF0 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed